Melperone Ratiopharm (Melperone Hydrochloride)

Melperone works by blocking dopamine D2 receptors in the brain, which decreases excessive dopaminergic activity that contributes to psychotic symptoms. This antagonism in key neural pathways helps to stabilize mood, reduce hallucinations, and improve thought processes.

The appropriate dose of melperone is individualized and determined by the prescribing clinician based on the patient’s condition, response, and tolerability. Dosage adjustments may be required for specific populations, and the prescriber will provide the exact regimen.

Safety data for melperone in pregnancy and lactation are limited, and the pregnancy category is listed as unknown. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and under close medical supervision.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Melperone shares the dopamine D2 antagonism common to typical antipsychotics such as haloperidol, but it is often considered to have a lower propensity for severe extrapyramidal side effects. Its pharmacokinetic profile may allow for once‑daily dosing in many patients, though individual response varies.

Melperone tablets should be stored at ambient temperature, below 25 °C, in the original packaging to protect them from moisture and light. Keep the container tightly closed and out of reach of children.

Melperone is taken orally as a tablet, usually with a glass of water. It can be taken with or without food, but patients should follow the prescribing clinician’s instructions regarding timing and any specific dietary considerations.

The most serious risks include neuroleptic malignant syndrome, a potentially life‑threatening reaction characterized by fever, muscle rigidity, and autonomic instability; tardive dyskinesia, which may cause irreversible involuntary movements; seizures; and agranulocytosis, a severe drop in white blood cells that can increase infection risk.

Melperone is contraindicated in patients with known hypersensitivity to melperone or any component of the formulation. Caution is advised for individuals with severe hepatic impairment, uncontrolled cardiovascular disease, or a history of neuroleptic malignant syndrome. It should also be avoided in patients taking medications that strongly inhibit CYP1A2 without appropriate monitoring.